Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CA9 ( clone G260S). We employs the pBR322 (T7-GFP-IL-17-XbaI) vector components and the SynExpress system of the exons Deletion/Negative feedback for a robust and sustained response against cancers.
Host
human
Target
CA9
Clone
G260S
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
IL-17
Insertion Sites
XbaI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
pBR322
Transformation Accuracy
0.98
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.